PubMed
Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract (review)
Sikiric et al., 2018
Healing & RecoveryResearch OnlyS
BPC-157 Stable
BPC-157 Stable Capsule
Stabilized oral BPC-157 variant marketed for GI-focused research protocols.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 3
- Research grade
- S
- Community score
- 55
- Trackers
- 741
Trend index
Overview
About BPC-157 Stable
Stabilized oral BPC-157 variant marketed for GI-focused research protocols.
- Category
- Healing & Recovery
- Regulatory status
- Research Only
- Also known as
- BPC-157 Stable Capsule
- Self-reports
- 6
Community
What 6 users report
6 community reports
Positive 0% · Neutral 100% · Negative 0%
Most reported benefits
Recovery
6
Dose distribution
Median: 200–400 mcg · Most common: 200–400 mcg
0–25
0
25–50
0
50–100
0
100–200
0
200–400
4
400–600
2
600–1000
0
1000–2000
0
2000+
0
Commonly stacked with
Research
Cited research (2)
Source
PubMed
Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract
Sikiric et al., 2018
Help
Frequently asked
What do PeptIQ users report about BPC-157 Stable?
This page summarizes 6 anonymized self-reports from PeptIQ users who track BPC-157 Stable, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
What research is cited for BPC-157 Stable?
2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is BPC-157 Stable safe to use?
This wiki does not assess safety or recommend use. BPC-157 Stable is listed as Research Only. Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of BPC-157 Stable?
Research, primarily in animal models, suggests BPC-157 Stable may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceWhat is the legal status of BPC-157 Stable?
BPC-157 Stable is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified BPC-157 Stable as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceWhat are the known or theoretical side effects and risks of BPC-157 Stable?
The safety and effectiveness of BPC-157 Stable have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhat is the current state of research on BPC-157 Stable?
While there are over 200 published studies on BPC-157 Stable, the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source